Medtronic to buy Covidien and head to Ireland

Medtronic to buy rival Covidien for $42.9B in cash and stock. The deal would move the combined company to Ireland. The U.S. corporate tax rate is 35%, among the world’s highest, while Ireland’s is as low as 12.5%

Advertisement